Page 131 - RusRPTSept23

9.1.13 Other sector news
American pharmaceutical firm MSD (Merck Corporation) has announced it will halt the supply of the hepatitis C drug Zepatier to Russia, Kommersant reported on August 23, citing the Russian regulator Roszdravnadzor.
The move comes as part of a larger trend of foreign pharmaceutical companies winding down their business in Russia due to sanctions.
Russian regulations mandate foreign suppliers of medications to provide at least a year's notice before ceasing the supply of a drug. MSD said that the decision to stop the deliveries of the Hepatitis drug would not impact the scheduled deliveries for the year 2024.
While Russia has an expanding pharmaceutical industry that got a huge boost from Russia’s development and global distribution of its Sputnik V anti-coronavirus drug in the last three years, Russia still trails in the
RUSSIA Country Report September 2023 www.intellinews.com